Evidence map›Paper›PMID 38846384›Full record

ReviewChemical science2024

Quinoxaline-based Y-type acceptors for organic solar cells.

Meiling Xie, Zhixiang Wei, Kun Lu

Abstract readReview
In one paragraph

Review in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Meiling XieCAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology Beijing 100190 China.
Zhixiang WeiCAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology Beijing 100190 China.ORCID https://orcid.org/0000-0001-6188-3634
Kun LuCAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology Beijing 100190 China.ORCID https://orcid.org/0000-0002-3403-2516

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Minimizing energy loss plays a critical role in the quest for high-performance organic solar cells (OSCs). However, the origin of large energy loss in OCSs is complicated, involving the strong exciton binding energy of organic semiconductors, nonradiative charge-transfer state decay, defective molecular stacking network, and so on. The recently developed quinoxaline (Qx)-based acceptors have attracted extensive interest due to their low reorganization energy, high structural modification possibilities, and distinctive molecular packing modes, which contribute to reduced energy loss and superior charge generation/transport, thus improving the photovoltaic performance of OSCs. This perspective summarizes the design strategies of Qx-based acceptors (including small-molecule, giant dimeric and polymeric acceptors) and the resulting optoelectronic properties and device performance. In addition, the ternary strategy of introducing Qx-based acceptors as the third component to reduce energy loss is briefly discussed. Finally, some perspectives for the further exploration of Qx-based acceptors toward efficient, stable, and industry-compatible OSCs are proposed.

Identifiers

PMID38846384
PMCPMC11151842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.